Michael J. Liptay, MD, is chief of the Division of Thoracic Surgery and associate professor in the Department of Cardiovascular-Thoracic Surgery at Rush University Medical Center.
Liptay is one of Chicago's leading lung cancer surgeons and researchers. He came to Rush from Evanston Northwestern Healthcare, where he was chief of the Division of Thoracic Surgery and co-director of their thoracic oncology program. He also served as an associate professor of surgery at Northwestern's Feinberg School of Medicine.
Liptay earned his Bachelor of Arts and medical degrees from Northwestern University as part of their accelerated honors program in medical education. After graduation, he completed his surgical residency at Barnes-Jewish Hospital in affiliation with Washington University in St. Louis. He later went to Harvard University Medical School for his subspecialty training. He completed a residency in cardiothoracic surgery at Brigham and Women's Hospital in Boston, where he served as chief resident in general thoracic surgery.
Throughout his career, Liptay has been actively involved in research. He has presented many papers and published extensively in the field of thoracic surgery. He has pioneered intraoperative sentinel lymph node mapping in lung cancer surgery and is the principal investigator of a national trial studying the technique. He is also a participant in the Early Lung Cancer Action Project (ELCAP), which is aimed at determining the value of early detection of lung cancer. He has been a leader in the application of minimally invasive techniques to the treatment of lung, esophageal and mediastinal tumors.
Liptay holds leadership roles in numerous professional and scientific organizations, including the board of directors of the Illinois Division of the American Cancer Society, the Cancer and Leukemia Group B's Thoracic Surgery Committee and the American College of Surgeons Oncology Group.